A patient taking gabapentin 300 mg three times daily and olanzapine (Zyprexa) 10 mg at night reports poor sleep with three nightly awakenings and continues smoking; what advice can be given to improve sleep?

Sleep Optimization in Patient on Gabapentin and Olanzapine

Increase the gabapentin dose to 600 mg three times daily (1800 mg/day total) and address the smoking-related sleep fragmentation through smoking cessation counseling, as the current 900 mg/day gabapentin dose is subtherapeutic for sleep improvement and nicotine addiction is directly causing the early awakenings.

Rationale for Gabapentin Dose Increase

Your patient is currently on gabapentin 300 mg TID (900 mg/day total), which is below the therapeutic range for sleep improvement. Gabapentin at 1800 mg/day has been shown to significantly increase sleep efficiency, reduce wake after sleep onset, and decrease spontaneous arousals 1. The FDA-approved dosing allows titration up to 3600 mg/day, with 1800 mg/day demonstrating optimal efficacy in clinical studies 2.

• Start by increasing to 600 mg TID (1800 mg/day) over 3 days
• This dose specifically improves slow-wave sleep and reduces nighttime awakenings 1, 3
• The current 900 mg/day dose is insufficient for sleep architecture benefits

The Smoking Problem is Critical

The three nightly awakenings are likely driven by nicotine withdrawal and early morning awakening patterns characteristic of nicotine addiction 4. Research demonstrates that:

• Nicotine addiction severity directly correlates with early awakening as the primary sleep disruption mechanism
• Early awakening (not difficulty falling asleep or mid-sleep awakenings) mediates the relationship between addiction and poor sleep 4
• Smokers experience withdrawal-driven arousals throughout the night

Smoking cessation must be addressed concurrently - consider:

• Nicotine replacement therapy (patch for overnight coverage)
• Varenicline or bupropion
• Behavioral counseling focused on the sleep-smoking connection

Olanzapine Considerations

The olanzapine 10 mg at night is appropriate and actually beneficial for sleep. Olanzapine increases total sleep time, sleep efficiency, and slow-wave sleep while reducing wake time 5, 6. The dose is within therapeutic range (20-40 ng/mL blood level corresponds to typical dosing) 7. Do not reduce this medication as it's likely helping, not hindering, sleep quality.

Critical Caveats

Avoid adding benzodiazepines or other sedative-hypnotics - the VA/DoD guidelines explicitly recommend against benzodiazepines for chronic insomnia due to dependency risk, falls, and cognitive impairment 8. The ACP guidelines prioritize cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment 9.

Monitor for gabapentin-related risks:

• Respiratory depression risk when combined with other CNS depressants 10
• Dose adjustment needed if renal impairment present 2
• Abuse potential exists, particularly in patients with substance use history 10

Implementation Algorithm

1. Week 1: Increase gabapentin to 600 mg TID (take with or without food, maximum 12 hours between doses) 2
2. Week 1: Initiate smoking cessation plan with overnight nicotine coverage
3. Week 2-4: Assess sleep improvement; if inadequate response at 1800 mg/day, consider further titration to 2400-3600 mg/day 2
4. Ongoing: Continue olanzapine 10 mg at bedtime unchanged
5. Refer for CBT-I if available, as this is the guideline-recommended first-line treatment 8, 9

The combination of optimized gabapentin dosing and smoking cessation addresses both the neurochemical sleep architecture deficits and the nicotine-driven early awakenings that are fragmenting this patient's sleep.